The Expression and Related Clinical Significance of SIRT3 in Non-Small-Cell Lung Cancer

Abstract EN

Objective.

To examine the relationship between the Sirtuin-3 (SIRT3) expression and the clinical indicators/prognosis of patients with non-small-cell lung cancer (NSCLC).

Methods.

The mRNA level of SIRT3 was detected by real-time PCR, while the protein level was detected by Western blot and immunohistochemical staining.

SPSS 16.0 software was used for statistical analysis.

Results.

The expression of SIRT3 was significantly higher in NSCLC tissue than in adjacent tissue.

The SIRT3 level was correlated significantly with lymph node metastasis and clinical stage of NSCLC patients.

Moreover, univariate analysis showed that the expression of SIRT3, tumor size, lymph node metastasis, degree of differentiation, and clinical stage were correlated with the prognosis of NSCLC patients.

Multivariate analysis demonstrated that lymph node metastasis, the tumor size, and SIRT3 expression were independent prognostic factors for NSCLC patients.

Conclusions.

SIRT3 is associated with the development and progression of NSCLC.

The SIRT3 expression can be used as an independent prognostic factor for NSCLC patients and help identify prognosis of NSCLC.

Therefore, SIRT3 has the potential to become a new factor for prognosis prediction and personalized treatment of NSCLC.